(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WARMX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

WARMX

ST13

US500000099087192

Class

1, 5

Filing

99087192

Registration

8020007

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

11/12/2025

Trademark type

Word

Nice classes

1, 5

Filing date

03/17/2025

Registration date

11/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/11/2025

Last transaction

11/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

06/12/2024

First use in commerce

06/12/2024

Drawing code

4

Owner type

16

Owner location

Beverly, MA

Examiner

EISNACH,MICHAEL PATRICK

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Qiagen Beverly, LLC

Representatives

Randolph E Digges, III RANKIN, HILL & CLARK LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemical and biotechnological diagnostic preparations used in sciencenon-medical reagentsenzymes and chemicalsnamely buffer solutionsused in analytical chemistryfor scientific and/or medical research use for markingseparatingisolatingamplifyingreverse transcribingcloningsequencing and for the analysis of biopolymersin particular nucleic acidsin particular reagentsenzymes and buffer solutions for nucleic acid amplificationreverse transcription and cloning; chemical test kits for laboratory and research use for markingseparatingisolatingamplifyingreverse transcribingcloningsequencing and for the analysis of biopolymersin particular nucleic acidsin particular comprising reagentsenzymes and buffer solutions for nucleic acid amplificationreverse transcription and cloning

Class 5

Diagnostic preparations for medical and veterinary purposesnamely diagnostics preparations for markingseparatingisolatingamplifyingreverse transcribingcloningsequencing and/or for the analysis of biopolymersnamely nucleic acids; diagnostic reagentsenzymes and buffer solutions for nucleic acid amplificationreverse transcription and cloning for medical or veterinary purposes; chemicalbiochemical and biotechnological diagnostic preparations for medical and veterinary purposesnamely reagentsenzymes and buffer solutions for markingseparatingisolatingamplifyingreverse transcribingcloningsequencing and for the analysis of biopolymersnamely nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposesnamely for markingseparatingisolatingamplifyingreverse transcribingcloningsequencing and for the analysis of biopolymersnamely nucleic acids; diagnostic kits containing reagentsenzymes and buffer solutions for nucleic acid amplificationreverse transcription and cloning for medical or veterinary purposes

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/23/2025

PUBO

PUBLISHED FOR OPPOSITION

09/23/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/17/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/26/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

08/26/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/26/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

08/26/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/26/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/25/2025

GNRT

NON-FINAL ACTION E-MAILED

08/25/2025

CNRT

NON-FINAL ACTION WRITTEN

08/25/2025

DOCK

ASSIGNED TO EXAMINER

08/15/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/17/2025

NWAP

NEW APPLICATION ENTERED

03/17/2025

MAFR

APPLICATION FILING RECEIPT MAILED

03/17/2025

Continuous trademark protection

Get notified about every new filing that threatens WARMX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.